DE69931316D1 - Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-Rezeptorblockern - Google Patents
Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-RezeptorblockernInfo
- Publication number
- DE69931316D1 DE69931316D1 DE69931316T DE69931316T DE69931316D1 DE 69931316 D1 DE69931316 D1 DE 69931316D1 DE 69931316 T DE69931316 T DE 69931316T DE 69931316 T DE69931316 T DE 69931316T DE 69931316 D1 DE69931316 D1 DE 69931316D1
- Authority
- DE
- Germany
- Prior art keywords
- aryl
- preparation
- nmda receptor
- receptor blockers
- cyclohexylamine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98115484 | 1998-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69931316D1 true DE69931316D1 (de) | 2006-06-22 |
Family
ID=8232474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69931316T Expired - Lifetime DE69931316D1 (de) | 1998-08-18 | 1999-08-09 | Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-Rezeptorblockern |
Country Status (24)
Country | Link |
---|---|
US (1) | US6184236B1 (de) |
JP (1) | JP3455142B2 (de) |
KR (1) | KR100341194B1 (de) |
CN (1) | CN1141936C (de) |
AR (1) | AR021770A1 (de) |
AT (1) | ATE326219T1 (de) |
AU (1) | AU756408B2 (de) |
BR (1) | BR9903779A (de) |
CA (1) | CA2280455A1 (de) |
DE (1) | DE69931316D1 (de) |
HR (1) | HRP990256A2 (de) |
HU (1) | HUP9902737A3 (de) |
ID (1) | ID23107A (de) |
IL (1) | IL131399A0 (de) |
MA (1) | MA26677A1 (de) |
MY (1) | MY133133A (de) |
NO (1) | NO993948L (de) |
NZ (1) | NZ337243A (de) |
PE (1) | PE20000955A1 (de) |
PL (1) | PL334949A1 (de) |
SG (1) | SG82014A1 (de) |
TR (1) | TR199902015A3 (de) |
YU (1) | YU38699A (de) |
ZA (1) | ZA995212B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003535851A (ja) * | 2000-06-06 | 2003-12-02 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 二環式シクロヘキシルアミン類およびそれらのnmda受容体アンタゴニストとしての使用 |
AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
DE10153345A1 (de) * | 2001-10-29 | 2003-05-08 | Gruenenthal Gmbh | Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen |
US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
CN103497114A (zh) * | 2007-06-29 | 2014-01-08 | 埃莫里大学 | 用于神经保护的nmda受体拮抗剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4032766A1 (de) | 1990-10-16 | 1992-04-30 | Basf Ag | Phenylpiperidinoylamine und diese enthaltende arzneimittel |
DE4117904A1 (de) | 1991-05-31 | 1992-12-03 | Basf Ag | Substituierte n-phenylpiperidine |
EP0503411B1 (de) | 1991-03-14 | 1995-11-29 | BASF Aktiengesellschaft | Substituierte N-Phenylpiperidine und Arzneimittel daraus |
JP3926390B2 (ja) | 1995-10-26 | 2007-06-06 | 三菱ウェルファーマ株式会社 | β3作業薬として有用なフェニルエタノールアミン化合物、その製法およびその製造における中間体 |
-
1999
- 1999-08-09 US US09/370,602 patent/US6184236B1/en not_active Expired - Fee Related
- 1999-08-09 AT AT99115114T patent/ATE326219T1/de not_active IP Right Cessation
- 1999-08-09 DE DE69931316T patent/DE69931316D1/de not_active Expired - Lifetime
- 1999-08-13 CA CA002280455A patent/CA2280455A1/en not_active Abandoned
- 1999-08-13 AR ARP990104079A patent/AR021770A1/es not_active Application Discontinuation
- 1999-08-13 NZ NZ337243A patent/NZ337243A/xx unknown
- 1999-08-13 IL IL13139999A patent/IL131399A0/xx unknown
- 1999-08-13 PE PE1999000826A patent/PE20000955A1/es not_active Application Discontinuation
- 1999-08-16 SG SG9903973A patent/SG82014A1/en unknown
- 1999-08-16 YU YU38699A patent/YU38699A/sh unknown
- 1999-08-16 ID IDP990791A patent/ID23107A/id unknown
- 1999-08-16 JP JP22965899A patent/JP3455142B2/ja not_active Expired - Fee Related
- 1999-08-16 ZA ZA9905212A patent/ZA995212B/xx unknown
- 1999-08-16 HU HU9902737A patent/HUP9902737A3/hu unknown
- 1999-08-16 MY MYPI99003508A patent/MY133133A/en unknown
- 1999-08-17 NO NO993948A patent/NO993948L/no unknown
- 1999-08-17 CN CNB991179110A patent/CN1141936C/zh not_active Expired - Fee Related
- 1999-08-17 AU AU44537/99A patent/AU756408B2/en not_active Ceased
- 1999-08-17 KR KR1019990033814A patent/KR100341194B1/ko not_active IP Right Cessation
- 1999-08-17 PL PL99334949A patent/PL334949A1/xx not_active Application Discontinuation
- 1999-08-17 BR BR9903779-3A patent/BR9903779A/pt not_active IP Right Cessation
- 1999-08-17 MA MA25736A patent/MA26677A1/fr unknown
- 1999-08-18 TR TR1999/02015A patent/TR199902015A3/tr unknown
- 1999-08-18 HR HR98115484.2A patent/HRP990256A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MY133133A (en) | 2007-10-31 |
HU9902737D0 (en) | 1999-10-28 |
AR021770A1 (es) | 2002-08-07 |
MA26677A1 (fr) | 2004-12-20 |
YU38699A (sh) | 2002-03-18 |
CN1141936C (zh) | 2004-03-17 |
BR9903779A (pt) | 2000-09-19 |
PE20000955A1 (es) | 2000-09-28 |
CA2280455A1 (en) | 2000-02-18 |
ID23107A (id) | 2000-02-24 |
JP2000109429A (ja) | 2000-04-18 |
ATE326219T1 (de) | 2006-06-15 |
ZA995212B (en) | 2000-02-18 |
KR100341194B1 (ko) | 2002-06-20 |
NZ337243A (en) | 2000-12-22 |
JP3455142B2 (ja) | 2003-10-14 |
CN1248439A (zh) | 2000-03-29 |
KR20000017343A (ko) | 2000-03-25 |
SG82014A1 (en) | 2001-07-24 |
HRP990256A2 (en) | 2000-04-30 |
NO993948L (no) | 2000-02-21 |
AU756408B2 (en) | 2003-01-09 |
AU4453799A (en) | 2000-05-04 |
PL334949A1 (en) | 2000-02-28 |
TR199902015A2 (xx) | 2000-03-21 |
IL131399A0 (en) | 2001-01-28 |
HUP9902737A2 (hu) | 2000-06-28 |
NO993948D0 (no) | 1999-08-17 |
TR199902015A3 (tr) | 2000-03-21 |
HUP9902737A3 (en) | 2001-01-29 |
US6184236B1 (en) | 2001-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69932994D1 (de) | Verfahren zur Herstellung von perfluoralkylierten Anilinderivaten | |
PT1009732E (pt) | 1-amino-alquilciclo-hexanos antagonistas do receptor nmda | |
NO994077D0 (no) | Fremgangsmåte for fremstilling av keramiske membraner | |
EE04277B1 (et) | Taksoidide klassi kuuluvate derivaatide valmistamismeetod | |
DE69913047D1 (de) | Verfahren zur Herstellung von Benzamid-Derivaten | |
DE60227718D1 (de) | Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen | |
NO983513D0 (no) | FremgangsmÕte for fremstilling av papir | |
DE69708271D1 (de) | Verfahren zur Herstellung von Benzolderivaten | |
NO20003454D0 (no) | FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4- | |
DE69931316D1 (de) | Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-Rezeptorblockern | |
DE69805887T2 (de) | Verfahren zur Herstellung von alpha-Bromolactamderivaten | |
DE59811806D1 (de) | Verwendung von ausgewählten phytostenolestern zur herstellung von hypocholesterinämischen mitteln | |
NO996432D0 (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
DE69902120T2 (de) | Verfahren zur Herstellung von Acetylenderivaten | |
DE69913635D1 (de) | Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten | |
DE60208365D1 (de) | Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln | |
TR199800068A3 (tr) | Benzofenon türevlerinin hazirlanmasina yönelik metodlar. | |
DE69820422D1 (de) | Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln | |
DE69806357D1 (de) | Verfahren zur Herstellung fotowirksamer Coumarinderivate | |
DE59914948D1 (de) | Verwendung von 1-(aminoalkyl)-3-chinoxalin-2-on-derivaten zur herstellung von als antioxidantien wirkenden zusammensetzungen | |
DE29716468U1 (de) | Meßvorrichtung zur Herstellung von Maßschuhen | |
NO20003077D0 (no) | FremgangsmÕte for fremstilling av klorbenzooksazolen | |
NO20013044L (no) | Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater | |
EE9900404A (et) | Arüülaminotriasolopüridiinide valmistamise meetod | |
EE03762B1 (et) | Protsess NMDA antagonistide valmistamiseks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |